Clinical Trials
5
Active:0
Completed:5
Trial Phases
2 Phases
Phase 1:1
Phase 4:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 4
2 (66.7%)Phase 1
1 (33.3%)Xiaflex® Plus Testosterone Treatment Pilot Study Protocol
- First Posted Date
- 2019-01-24
- Last Posted Date
- 2020-12-31
- Lead Sponsor
- Men's Health Boston
- Target Recruit Count
- 20
- Registration Number
- NCT03815331
- Locations
- 🇺🇸
Men's Health Boston, Chestnut Hill, Massachusetts, United States
Subcutaneous vs. Intramuscular Testosterone
- First Posted Date
- 2017-03-27
- Last Posted Date
- 2019-10-08
- Lead Sponsor
- Men's Health Boston
- Target Recruit Count
- 4
- Registration Number
- NCT03091348
- Locations
- 🇺🇸
Men's Health Boston, Chestnut Hill, Massachusetts, United States
Diurnal Testosterone Concentration
Completed
- Conditions
- Testosterone Deficiency
- First Posted Date
- 2017-03-27
- Last Posted Date
- 2018-03-27
- Lead Sponsor
- Men's Health Boston
- Target Recruit Count
- 24
- Registration Number
- NCT03091296
- Locations
- 🇺🇸
Men's Health Boston, Chestnut Hill, Massachusetts, United States
Metabolomics During Testosterone Therapy
- First Posted Date
- 2013-10-16
- Last Posted Date
- 2018-04-19
- Lead Sponsor
- Men's Health Boston
- Target Recruit Count
- 60
- Registration Number
- NCT01963390
- Locations
- 🇺🇸
Men's Health Boston, Chestnut Hill, Massachusetts, United States
Testosterone Pellets Plus Vitamin D and E Versus Vitamin D and E Alone for the Treatment of Peyronie's Disease
Phase 1
Completed
- Conditions
- Peyronie's Disease
- Interventions
- First Posted Date
- 2012-04-17
- Last Posted Date
- 2018-03-29
- Lead Sponsor
- Men's Health Boston
- Target Recruit Count
- 75
- Registration Number
- NCT01578473
- Locations
- 🇺🇸
Men's Health Boston, Chestnut Hill, Massachusetts, United States
News
No news found